, Tracking Stock Market Picks
Enter Symbol:
Idenix Pharmaceuticals, Inc. (IDIX) [hlAlert]

up 370.24 %

Idenix Pharmaceuticals, Inc. (IDIX) rated Buy with price target $7 by Deutsche Bank

Posted on: Wednesday,  Nov 28, 2012  1:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) on 11/28/2012, when the stock price was $5.21. Since
then, Idenix Pharmaceuticals, Inc. has gained 370.25% as of 08/05/2014's recent price of $24.50.
If you would have followed this Deutsche Bank's recommendation on IDIX, you would have gained 370.24% of your investment in 615 days.

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/28/2012 1:25 PM Buy
5.21 7.00
as of 12/31/2012
1 Week down  -0.61 %
1 Month down  -5.08 %
3 Months down  -6.90 %
1 YTD down  -6.90 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy